Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1076-1083, doi:10.1016/j.jacc.2008.05.055
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorian, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dorian, P.
Related Collections
Right arrowRelated Articles

Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial

Paul Dorian, MD, FACC*,*, Hussein R. Al-Khalidi, PhD, FAHA{dagger}, Stefan H. Hohnloser, MD, FACC{ddagger}, Jose M. Brum, MD, MSc{dagger}, Preston M. Dunnmon, MD, FACC{dagger}, Craig M. Pratt, MD, FACC§, Michael J. Holroyde, PhD{dagger}, Peter Kowey, MD, FACC|| on behalf of the SHIELD (SHock Inhibition Evaluation with AzimiLiDe) Investigators

* Division of Cardiology, St. Michael's Hospital/University of Toronto, Toronto, Ontario, Canada
{dagger} Health Care Research Center, Procter & Gamble Pharmaceuticals, Cincinnati, Ohio
{ddagger} Department of Cardiology, Division of Electrophysiology, J.W. Goethe-University, Frankfurt, Germany
§ Methodist DeBakey Heart Center, Houston, Texas
|| Division of Cardiovascular Diseases, Jefferson Medical College, Philadelphia, Pennsylvania


Figure 1
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Kaplan-Meier Cumulative Incidence of Cardiac Arrhythmic-Related ED Visits and Hospitalizations

AZ = azimilide; ED = emergency department; RRR = relative risk reduction.

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Cumulative Risk of Recurrent Cardiac-Related ED Visits or Hospitalizations Over Time by Treatment Group

The slope of each curve represents the estimated rate of total cardiac-related ED visits or hospitalizations within each group. Abbreviations as in Figure 1.

 

Figure 3
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Kaplan-Meier Cumulative Incidence of Cardiac Arrhythmic-Related ED Visits and Hospitalizations

ATP = antitachycardia pacing; ED = emergency department; ICD = implantable cardioverter-defibrillator.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement